Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.

@article{Koren2009FocusedAT,
  title={Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.},
  author={Michael Koren and Michael H. Davidson and Daniel J. Wilson and Rana S. Fayyad and Andrea Zuckerman and David P. Reed},
  journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
  year={2009},
  volume={53 5},
  pages={741-50}
}
BACKGROUND This post hoc analysis of the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) Study investigates the effect of focused atorvastatin therapy versus usual care on cardiovascular outcomes in patients with coronary heart disease (CHD) with and without chronic kidney disease (CKD). STUDY DESIGN Prospective randomized open-label; median follow-up, 54.3 months. SETTING & PARTICIPANTS Managed care or Veterans Affairs facilities; 2,442 patients with CHD with… CONTINUE READING